Microcystic, elongated, and fragmented (MELF) pattern of myometrial invasion in grade 1–2 endometrioid endometrial carcinoma: clinicopathological associations, molecular profile, and prognostic significance under FIGO 2023 staging
Rattachement africain : tr. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: The microcystic, elongated, and fragmented (MELF) pattern of myometrial invasion is a morphological feature of endometrioid endometrial carcinoma (EEC) with debated prognostic significance. Most prior studies evaluated MELF across heterogeneous histologic grades and predate the FIGO 2023 staging system. We assessed MELF prevalence in a uniform Grade 1-2 EEC cohort and its clinicopathological, molecular, and survival associations. Methods: We retrospectively reviewed 112 patients with Grade 1-2 EEC surgically treated at a tertiary center (2015-2023). MELF status was determined by pathology re-review, and molecular profiling used immunohistochemistry (IHC) for mismatch repair (MMR) proteins, p53, and hormone receptors. Associations were assessed with Fisher's exact and Mann-Whitney U tests; survival was analyzed by Kaplan-Meier, log-rank, and Cox regression with Firth penalization. Results: MELF was identified in 43/112 patients (38.4%). MELF-positive tumors were significantly associated with deep myometrial invasion (65.1% vs. 24.6%; OR 5.71, 95% CI 2.44-13.35), lymphovascular space invasion (LVSI: 58.1% vs. 11.6%; OR 10.59, 95% CI 4.01-27.95), cervical stromal invasion (32.6% vs. 10.1%; OR 4.28, 95% CI 1.55-11.82; all p ≤ 0.005), and larger tumor size (median 3.7 vs. 3.0 cm; p=0.015). MELF was not associated with deficient mismatch repair (OR 1.48, p=0.39) or p53 mutant-type expression (OR 0.96, p=1.00). At a median follow-up of 54.5 months (9 deaths), MELF-positive patients showed numerically worse overall survival that did not reach statistical significance (log-rank p=0.059). On Firth-penalized Cox regression, deep myometrial invasion was the only significant univariate predictor (HR 7.12, p=0.036); the MELF survival signal attenuated to near-unity when depth of invasion was added. Conclusions: In Grade 1-2 EEC, MELF is a frequent pattern (38.4%) that reliably flags aggressive local invasion, including cervical stromal invasion relevant to FIGO 2023 upstaging. Its survival association was largely shared with depth of myometrial invasion rather than independent of it; MELF is therefore best regarded as a morphological marker of an aggressive phenotype rather than an independent prognostic factor. Being independent of mismatch repair and p53 status, MELF may aid risk assessment within the presumed no-specific-molecular-profile (NSMP-like) subgroup. Routine pathological reporting of MELF can prompt assessment of depth of invasion and high-risk features.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Microcystic, elongated, and fragmented (MELF) pattern of myometrial invasion in grade 1–2 endometrioid endometrial carcinoma: clinicopathological associations, molecular profile, and prognostic significance under FIGO 2023 staging
- Date Crossref
- 13/08/2026
- Éditeur
- Frontiers Media SA
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Dokuz Eylül University Department of Obstetrics and Gynecology pays non établi dans la noticeUniversité ou école supérieure
-
Izmir Atatürk Eğitim ve Araştırma Hastanesi pays non établi dans la noticeÉtablissement de santé
-
Izmir Ataturk Research and Training Hospital Department of Pathology pays non établi dans la noticeÉtablissement de santé
Department of Obstetrics and Gynecology — Dokuz Eylül University, Izmir Atatürk Eğitim ve Araştırma Hastanesi et Department of Pathology — Izmir Ataturk Research and Training Hospital.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.